SensNewsJan2017

21 / 25

21 Sensor100 January 2017
Five Predictions for HealthTech and Services in 2017
By Dan Gebremedhin MD, MBA*
1. The 21st Century Cures Act makes “RealWorld Evidence” a buzzword in
pharma and payer circles, and justifiably so
2. Clinical Decision Support moves into the world of Prescriptive Analytics and
finally takes root
3. MACRA spells the end of the standalone primary care provider and health
tech looks to fill the void
4. Start-ups develop a “high risk” appetite and target “node” conditions in high
risk populations such as Medicare Advantage and Dual Eligibles
5. Health tech industry innovation will not waver over the next 4 years, it will
subscribe to republican orthodoxy and free market forces
* The author is a Principal at Flare Capital Partners, an early stage Health Technology
and Services focusedVC Firm. He is a practicing physician at the Massachusetts Gen-
eral Hospital.
Reported by 27 January
Alphabet’sVerily life sciences company lands $800M investment
fromTemasek
Alphabet’s health-focused subsidiaryVerily, formerly Google Life Sciences, has received
an $800 million investment fromTemasek, an investment company based in Singapore
Reported by 26 January
Smart-CutaneousWearables-Medical Device Alert
This edition of Medical Device Alert depicts trends across smart-cutaneous wear-
ables, with advancements in health monitoring. The Medical Device Alert analyses and
reports on new and emerging technologies and advances in R&D; product develop-
ment; and regulatory matters related to neurology, ophthalmology, respiratory/anes-
thesia, wound care and management, surgical tools and instrumentation, drug delivery,
orthopedics, endoscopy, cardiology, and monitoring.
pril 2016